Ionis Pharmaceuticals, Inc.
MX ˙ BMV ˙ US4622221004
SecurityMX:IONS / Ionis Pharmaceuticals, Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership2,078 shares
Latest Disclosed Value $ 156,037
Signaturefd, Llc reports 1.81% increase in ownership of IONS / Ionis Pharmaceuticals, Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 2,078 shares of Ionis Pharmaceuticals, Inc. (MX:IONS) valued at $156,037 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 2,041 shares of Ionis Pharmaceuticals, Inc.. This represents a change in shares of 1.81% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F IONIS PHARMACEUTICALS COM 462222100 2,078 37 1.81 156 -3.11 0.0024
2026-01-20 2025-12-31 13F IONIS PHARMACEUTICALS COM 462222100 2,041 38 1.90 161 22.90 0.0025
2025-10-21 2025-09-30 13F IONIS PHARMACEUTICALS COM 462222100 2,003 -27 -1.33 131 63.75 0.0021
2025-07-16 2025-06-30 13F IONIS PHARMACEUTICALS COM 462222100 2,030 648 46.89 80 95.12 0.0014
2025-05-02 2025-03-31 13F IONIS PHARMACEUTICALS COM 462222100 1,382 433 45.63 42 24.24 0.0008
2025-02-10 2024-12-31 13F IONIS PHARMACEUTICALS COM 462222100 949 584 160.00 33 135.71 0.0006
2024-10-21 2024-09-30 13F IONIS PHARMACEUTICALS COM 462222100 365 25 7.35 15 -12.50 0.0003
2024-07-29 2024-06-30 13F IONIS PHARMACEUTICALS COM 462222100 340 -15 -4.23 16 6.67 0.0003
2024-05-03 2024-03-31 13F IONIS PHARMACEUTICALS COM 462222100 355 -146 -29.14 15 -40.00 0.0003
2024-02-01 2023-12-31 13F IONIS PHARMACEUTICALS COM 462222100 501 135 36.89 25 56.25 0.0006
2023-11-03 2023-09-30 13F IONIS PHARMACEUTICALS COM 462222100 366 -110 -23.11 17 -15.79 0.0004
2023-08-01 2023-06-30 13F IONIS PHARMACEUTICALS COM 462222100 476 254 114.41 20 171.43 0.0005
2023-04-28 2023-03-31 13F IONIS PHARMACEUTICALS COM 462222100 222 -9 -3.90 8 -12.50 0.0002
2023-01-30 2022-12-31 13F IONIS PHARMACEUTICALS COM 462222100 231 -17 -6.85 9 -27.27 0.0003
2022-11-08 2022-09-30 13F IONIS PHARMACEUTICALS COM 462222100 248 6 2.48 11 22.22 0.0004
2022-08-10 2022-06-30 13F IONIS PHARMACEUTICALS COM 462222100 242 -299 -55.27 9 -55.00 0.0003
2022-05-02 2022-03-31 13F IONIS PHARMACEUTICALS COM 462222100 541 -135 -19.97 20 -4.76 0.0006
2022-01-25 2021-12-31 13F IONIS PHARMACEUTICALS COM 462222100 676 -210 -23.70 21 -30.00 0.0006
2021-10-28 2021-09-30 13F IONIS PHARMACEUTICALS COM 462222100 886 -87 -8.94 30 -23.08 0.0010
2021-07-26 2021-06-30 13F IONIS PHARMACEUTICALS COM 462222100 973 194 24.90 39 11.43 0.0016
2021-04-30 2021-03-31 13F IONIS PHARMACEUTICALS COM 462222100 779 154 24.64 35 0.00 0.0015
2021-02-11 2020-12-31 13F IONIS PHARMACEUTICALS COM 462222100 625 -33 -5.02 35 12.90 0.0016
2020-11-03 2020-09-30 13F IONIS PHARMACEUTICALS COM 462222100 658 43 6.99 31 -13.89 0.0017
2020-07-30 2020-06-30 13F IONIS PHARMACEUTICALS COM 462222100 615 -38 -5.82 36 16.13 0.0022
2020-04-23 2020-03-31 13F IONIS PHARMACEUTICALS COM 462222100 653 44 7.22 31 -16.22 0.0027
2020-02-05 2019-12-31 13F IONIS PHARMACEUTICALS COM 462222100 609 -64 -9.51 37 -7.50 0.0027
2019-10-16 2019-09-30 13F IONIS PHARMACEUTICALS COM 462222100 673 0 0.00 40 -6.98 0.0033
2019-07-31 2019-06-30 13F IONIS PHARMACEUTICALS COM 462222100 673 35 5.49 43 -17.31 0.0037
2019-05-09 2019-03-31 13F IONIS PHARMACEUTICALS COM 462222100 638 -17 -2.60 52 48.57 0.0044
2019-02-13 2018-12-31 13F IONIS PHARMACEUTICALS COM 462222100 655 -24 -3.53 35 0.00 0.0033
2018-11-14 2018-09-30 13F IONIS PHARMACEUTICALS COM 462222100 679 -30 -4.23 35 16.67 0.0036
2018-08-14 2018-06-30 13F IONIS PHARMACEUTICALS COM 462222100 709 404 132.46 30 130.77 0.0033
2018-05-08 2018-03-31 13F IONIS PHARMACEUTICALS COM 462222100 305 305 13 0.0015
2017-02-14 2016-12-31 13F IONIS PHARMACEUTICALS COM 462222100 0 -191 -100.00 0 -100.00
2016-11-14 2016-09-30 13F IONIS PHARMACEUTICALS COM 462222100 191 191 0.00 7 0.0010
2016-05-12 2016-03-31 13F IONIS PHARMACEUTICALS COM 462222100 0 -43 -100.00 0 -100.00
2016-01-22 2015-12-31 13F IONIS PHARMACEUTICALS COM 462222100 43 0 0.00 3 50.00 0.0006
2015-10-23 2015-09-30 13F ISIS PHARMACEUTICALS COM 464330109 43 43 2 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.